Evaluation of ischemia-modified albumin in the diagnosis and the clinical severity of COVID-19 in children.

The Turkish journal of pediatrics(2023)

引用 0|浏览19
暂无评分
摘要
To date, no study has been conducted on IMA levels in children with COVID-19. The IMA level may be a new marker for the diagnosis of COVID-19 in children. Studies with a larger number of cases are needed to predict clinical severity.
更多
查看译文
关键词
ischemia-modified albumin, COVID-19, child, diagnosis, clinical severity
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要